Similar articles

• Knockdown of TRIM65 inhibits lung cancer cell proliferation, migration and invasion: A therapeutic target in human lung cancer.

  Wang XL, Shi WP, Shi HC, Lu SC, Wang K, Sun C, He JS, Jin WG, Lv XX, Zou H, Shu YS. Wang XL, et al. Oncotarget. 2016 Dec 6;7(49):81527-81540. doi: 10.18632/oncotarget.13131. Oncotarget. 2016. Retraction in: Oncotarget. 2024 May 16;15:312. doi: 10.18632/oncotarget.28571. PMID: 27829229 Free PMC article. Retracted.
• Long Noncoding RNA MALAT1 Knockdown Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis in Non-Small-Cell Lung Cancer Cells Through Regulating miR-515-3p/TRIM65 Axis.

  Wang Y, Zhang Q. Wang Y, et al. Cancer Biother Radiopharm. 2020 Dec 31. doi: 10.1089/cbr.2020.3730. Online ahead of print. Cancer Biother Radiopharm. 2020. PMID: 33395541
• Knockdown of TRIM65 suppressed the proliferation and invasiveness of gastric cancer cells by restricting the ubiquitin degradation of PPM1A.

  Liu C, Sun W, Yang K, Xia B. Liu C, et al. Exp Cell Res. 2022 Jul 15;416(2):113154. doi: 10.1016/j.yexcr.2022.113154. Epub 2022 Apr 11. Exp Cell Res. 2022. PMID: 35421368
• Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis.

  Guo C, Wang H, Jiang H, Qiao L, Wang X. Guo C, et al. Cancer Biother Radiopharm. 2022 Mar;37(2):84-95. doi: 10.1089/cbr.2019.3546. Epub 2020 Aug 20. Cancer Biother Radiopharm. 2022. PMID: 32833503
• TRIM65 Promotes Cervical Cancer Through Selectively Degrading p53-Mediated Inhibition of Autophagy and Apoptosis.

  Wang XY, Mao HW, Guan XH, Huang QM, Yu ZP, Wu J, Tan HL, Zhang F, Huang X, Deng KY, Xin HB. Wang XY, et al. Front Oncol. 2022 Mar 24;12:853935. doi: 10.3389/fonc.2022.853935. eCollection 2022. Front Oncol. 2022. PMID: 35402260 Free PMC article.